1. Home
  2. TENX vs GFAI Comparison

TENX vs GFAI Comparison

Compare TENX & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • GFAI
  • Stock Information
  • Founded
  • TENX 1967
  • GFAI 2018
  • Country
  • TENX United States
  • GFAI Singapore
  • Employees
  • TENX N/A
  • GFAI N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • TENX Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • TENX 27.3M
  • GFAI 23.5M
  • IPO Year
  • TENX N/A
  • GFAI N/A
  • Fundamental
  • Price
  • TENX $6.37
  • GFAI $1.15
  • Analyst Decision
  • TENX Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • TENX 4
  • GFAI 1
  • Target Price
  • TENX $16.67
  • GFAI $4.50
  • AVG Volume (30 Days)
  • TENX 47.8K
  • GFAI 517.0K
  • Earning Date
  • TENX 11-12-2025
  • GFAI 09-25-2025
  • Dividend Yield
  • TENX N/A
  • GFAI N/A
  • EPS Growth
  • TENX N/A
  • GFAI N/A
  • EPS
  • TENX N/A
  • GFAI N/A
  • Revenue
  • TENX N/A
  • GFAI $36,347,373.00
  • Revenue This Year
  • TENX N/A
  • GFAI $5.66
  • Revenue Next Year
  • TENX N/A
  • GFAI $4.69
  • P/E Ratio
  • TENX N/A
  • GFAI N/A
  • Revenue Growth
  • TENX N/A
  • GFAI 0.18
  • 52 Week Low
  • TENX $3.25
  • GFAI $0.76
  • 52 Week High
  • TENX $7.89
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • TENX 69.69
  • GFAI 51.82
  • Support Level
  • TENX $6.02
  • GFAI $1.10
  • Resistance Level
  • TENX $6.50
  • GFAI $1.19
  • Average True Range (ATR)
  • TENX 0.15
  • GFAI 0.06
  • MACD
  • TENX 0.04
  • GFAI 0.01
  • Stochastic Oscillator
  • TENX 78.56
  • GFAI 65.68

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

Share on Social Networks: